Indications:
Amphocil is indicated for the treatment of severe systemic and/or deep mycoses in cases where toxicity or renal failure precludes the use of conventional amphotericin B in effective doses, and in cases where prior systemic antifungal therapy has failed. Fungal infections successfully treated with Amphocil include disseminated candidiasis and aspergillosis. Amphocil has been used successfully in severely neutropenic patients.

Amphocil is not intended for use in common, clinically inapparent fungal diseases diagnosed only by skin test2s or serological determinations.

Pictured above right: Aspergillosis - PAS stained sputum of patient with Aspergillus flavus. (Click Here for More Information)

This Web site is intended and designed specifically for healthcare professionals from Greece and Cyprus only.

| Fungal Infections | Indications for Use | Dosage and Administration | Samaritan Pharmaceuticals |
| Prescribing Information (PDF) | Safety Information | Contact Us | Resources | Home |

| Privacy Information |